Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$35.55 - $43.57 $1.36 Million - $1.67 Million
-38,355 Reduced 63.24%
22,293 $968,000
Q3 2023

Oct 31, 2023

BUY
$39.13 - $47.24 $944,754 - $1.14 Million
24,144 Added 66.14%
60,648 $2.46 Million
Q2 2023

Aug 11, 2023

SELL
$43.93 - $46.76 $3.51 Million - $3.74 Million
-79,971 Reduced 68.66%
36,504 $1.64 Million
Q1 2023

May 11, 2023

BUY
$45.29 - $50.76 $4.31 Million - $4.83 Million
95,223 Added 448.07%
116,475 $5.35 Million
Q4 2022

Feb 13, 2023

BUY
$41.91 - $50.48 $890,671 - $1.07 Million
21,252 New
21,252 $1.06 Million
Q4 2021

Feb 10, 2022

SELL
$50.62 - $56.47 $262,363 - $292,684
-5,183 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$46.28 - $52.75 $19,854 - $22,629
-429 Reduced 7.64%
5,183 $251,000
Q1 2021

May 12, 2021

BUY
$46.25 - $56.02 $115,717 - $140,162
2,502 Added 80.45%
5,612 $273,000
Q4 2020

Feb 10, 2021

SELL
$46.09 - $54.74 $5,576 - $6,623
-121 Reduced 3.74%
3,110 $164,000
Q3 2020

Nov 13, 2020

BUY
$42.51 - $52.42 $19,597 - $24,165
461 Added 16.64%
3,231 $169,000
Q2 2020

Aug 12, 2020

SELL
$39.49 - $44.36 $79,888 - $89,740
-2,023 Reduced 42.21%
2,770 $119,000
Q1 2020

May 14, 2020

BUY
$33.17 - $41.6 $51,015 - $63,980
1,538 Added 47.25%
4,793 $199,000
Q4 2019

Feb 12, 2020

BUY
$25.41 - $43.1 $12,323 - $20,903
485 Added 17.51%
3,255 $110,000
Q1 2018

May 15, 2018

SELL
$31.01 - $34.72 $8.94 Million - $10 Million
-288,337 Reduced 99.05%
2,770 $89,000
Q4 2017

Feb 14, 2018

SELL
$30.68 - $35.37 $2.12 Million - $2.45 Million
-69,138 Reduced 19.19%
291,107 $9 Million
Q3 2017

Nov 14, 2017

BUY
$31.02 - $32.94 $11.2 Million - $11.9 Million
360,245
360,245 $11.3 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.2B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.